about the author

Josh Sullivan

josh@endpointsnews.com

author articles

Covid-19 roundup: No­vavax shakes up lead­er­ship with two pro­mo­tions and de­par­ture of CFO; Mod­er­na, No­vavax shots added ...

5 years ago
Coronavirus

Amy­lyx to move for­ward with ALS pro­gram in Eu­rope, but FDA wants an­oth­er look; Hu­ma­cyte adds $50M in debt fi­nanc­ing

5 years ago
News Briefing

Re­cur­sion lays out $300M+ goal in IPO terms; Evotec and Bris­tol My­ers team up to spin out Ger­man re­search

5 years ago
News Briefing

Covid-19 roundup: Cit­ing a lack of need, Gilead cuts remde­sivir study; No­vavax vac­cine pro­duc­tion slowed due to ...

5 years ago
Coronavirus

End­points ex­clu­sive: Bob Nelsen's Re­silience snags Flori­da CD­MO work­ing with the De­fense De­part­ment on Covid-19 ...

5 years ago
Deals

Sanofi un­veils $476M vac­cine plant in Sin­ga­pore, bring­ing its to­tal out­lay to $1.7B in the field for past year

5 years ago
Deals
Manufacturing

Lay­ing claim to an­oth­er AI 'first,' Ex­sci­en­tia tees up an I/O drug for the clin­ic

5 years ago
R&D
AI

Seat­tle-based Remiges Ven­tures to launch in­cu­ba­tor af­ter heavy in­vest­ment from Japan; Schrödinger signs lease on new ...

5 years ago
News Briefing

Man­u­fac­tur­ing brief­ing: Af­ter J&J-Emer­gent mix­up, few­er dos­es ex­pect­ed in US next week; Boehringer taps Ox­ford for ...

5 years ago
R&D
Manufacturing

CD­MO Ster­ling ac­quires ADC Bio, ramp­ing up ca­pac­i­ty for an­ti­body-drug con­ju­gate man­u­fac­tur­ing work

5 years ago
Deals
Manufacturing

Re­call re­port: A-S pulls near­ly 200,000 ac­eta­minophen bot­tles off shelves; Apo­tex yanks AD­HD med

5 years ago
Pharma
FDA+

Fe­male en­tre­pre­neurs have long been un­der­rep­re­sent­ed in biotech. An MIT team de­cid­ed to find out why

5 years ago
People
Financing

Covid-19 roundup: As­traZeneca paus­es vac­cine tri­al for chil­dren as blood clot probe con­tin­ues; EMA to in­ves­ti­gate ...

5 years ago
Coronavirus

Catal­ent pledges to in­crease pro­duc­tion of Mod­er­na vac­cine at its In­di­ana fill-fin­ish plant

5 years ago
Deals
Manufacturing

Af­ter No­var­tis walks on last STING drug, Chi­nook spits out or­phan Aduro as­sets

5 years ago
Deals

As Covid-19 vac­cine was be­ing de­vel­oped, Mod­er­na shelled out more than $1M for top ex­ec­u­tives' se­cu­ri­ty

5 years ago
People
Pharma

Covid-19 roundup: FDA up­dates Mod­er­na vac­cine dose per vial counts; Vir's an­ti­body shows promise against vari­ants

5 years ago
Coronavirus

Pe­ter Thiel jumps aboard Al­loy's lat­est $75M round, adding some heft to the an­ti­body dis­cov­ery out­fit's nascent ...

5 years ago
Financing

Al­ca­mi ap­points new CEO in Patrick Walsh, the ex­ec­u­tive who helped lead the CD­MO's pre­de­ces­sor com­pa­ny

5 years ago
People
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Catal­ent gets the FDA's go-ahead on J&J shot; As­traZeneca taps a new con­trac­tor

5 years ago
Coronavirus
Manufacturing

Covid-19 roundup: Emer­gen­t's er­ror costs J&J a vac­cine batch; Pfiz­er head says EU re­stric­tions slow vac­cine ...

5 years ago
Coronavirus
Manufacturing

US spe­cial coun­sel looks in­to al­leged mis­con­duct at Mer­ck plant prep­ping to make J&J shot — and in­dif­fer­ence from ...

5 years ago
Manufacturing

TCR² plants its flag in for­mer Au­to­lus man­u­fac­tur­ing site, plan­ning to add 175 jobs as it ad­vances lead T cell ...

5 years ago
R&D
Manufacturing

Look­ing to pre­pare for the next flu pan­dem­ic, Sanofi drops $700M+ in­to new Toron­to fa­cil­i­ty for Flu­zone pro­duc­tion

5 years ago
R&D
Manufacturing
First page Previous page 2526272829 Next page Last page
A service from the Financial Times